Maspex to expand its pharmaceuticals presence

Leading Polish food processing group Maspex has applied to the anti-monopoly watchdog UOKiK for acquiring a 44 percent stake in pharmaceutical company Sequoia from Paan Capital, ISBnews reported citing the firm. A preliminary deal has been already signed. "The strategic goal of Sequia is building an innovative pharmaceutical firm. The investment of Maspex Wadowice will grant us an opportunity for further dynamic development," said Jarosław Wypych, the CEO at Sequia. Sequia offers pharmaceuticals for babies and pregnant women. Since 2003, Maspex has been the owner of another pharmaceutical company, Polski Lek.